Hrt Financial LP Landec Corp \Ca\ Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	N/A	19,353 New	19,353 $119,000
Q2 2023 Aug 11, 2023	BUY	N/A	28,459 New	28,459 $275,000
Q1 2022 May 16, 2022	SELL	$10.07 - $11.93 $312,139 - $369,794	-30,997 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.95 - $11.24 $72,909 - $103,082	9,171 Added 42.02%	30,997 $344,000
Q3 2021 Nov 15, 2021	BUY	$9.22 - $12.44 $61,100 - $82,439	6,627 Added 43.6%	21,826 $201,000
Q2 2021 Aug 16, 2021	BUY	$9.91 - $12.78 $150,622 - $194,243	15,199 New	15,199 $170,000

20.3M

79.7K

31.6K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.